Image and performance enhancing drugs and cardiovascular health
The Image and Performance Enhancing Drugs and Cardiovascular Health subgroup investigates the cardiovascular consequences of IPED use across recreational gym users to competitive bodybuilders.
Our research aims to better understand the mechanisms of drug-related cardiovascular risk and inform strategies to improve awareness, detection, and harm reduction.

The growing use of image and performance enhancing drugs presents an emerging cardiovascular health challenge. Our research aims to better understand their impact on the heart and generate evidence that can inform education, prevention, and safer practice within the fitness community.

David Oxborough
Sub-Group Lead, RISES
Research
Our research adopts a multidisciplinary approach, integrating sports cardiology, nutrition, lipidomics, and advanced cardiovascular imaging to better understand the physiological and pathological consequences of IPED use.
Through this work, we aim to identify the cardiovascular risks associated with these substances and develop evidence-based strategies to raise awareness, improve detection, and ultimately reduce harm within these populations.
